Skip to main content
. 2011 Oct 3;22(2):122–137. doi: 10.1002/rmv.713

Figure 2.

Figure 2

Antiviral therapy options. Current therapy involves antiviral drugs, vaccination, and IFNα therapy for treatment of HCV patients. In addition to these therapies, treatment with type I and III IFNs can counteract acute and local infections, TLR ligands have shown to be beneficial in various viral infections, and DC transfer could be attractive where dysfunctional or limited numbers of DCs contribute to the pathogenesis